| Bioactivity | Ulipristal (CDB 3236) is a selective progesterone receptor modulator (SPRM). Ulipristal binds to the progesteron receptor, thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system[1]. | ||||||||||||
| In Vivo | Ulipristal (CDB 3236) may suppress the growth of uterine leiomyomatosis. By inhibiting or delaying ovulation and effecting endometrial tissue, ulipristal can be used as an emergency contraception[1]. | ||||||||||||
| Name | Ulipristal | ||||||||||||
| CAS | 159811-51-5 | ||||||||||||
| Formula | C28H35NO3 | ||||||||||||
| Molar Mass | 433.58 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. LIANA PLES, et al. Is Ulipristal Acetate a Liver Toxic Biomolecule? Toxicity assessment of ulipristal acetate. REV.CHIM.(Bucharest). |
Ulipristal
CAS: 159811-51-5 F: C28H35NO3 W: 433.58
Ulipristal (CDB 3236) is a selective progesterone receptor modulator (SPRM). Ulipristal binds to the progesteron recepto
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.